Hib-DTP-hepatitis B vaccine - GlaxoSmithKline

Drug Profile

Hib-DTP-hepatitis B vaccine - GlaxoSmithKline

Alternative Names: DTPw-HBV-Hib; DTPw-HBV/Hib

Latest Information Update: 25 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 25 Jan 2008 Discontinued - Clinical-Phase-Unknown for Diphtheria in Philippines (IM)
  • 25 Jan 2008 Discontinued - Clinical-Phase-Unknown for Haemophilus infections in Philippines (IM)
  • 25 Jan 2008 Discontinued - Clinical-Phase-Unknown for Hepatitis B in Philippines (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top